POMC and carcinoid tumor: This 55% sensitivity is lower than the 69–96% sensitivity described for midgut or hindgut carcinoids with no EAS (27), (28), (29), and suggests that carcinoids take up DOPA more efficiently than nonsecreting or ACTH-secreting NETs.